Home › Precursor T-Cell Lymphoblastic Leukemia-Lymphoma › Colorado
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma clinical trials in Colorado
3 studies for Precursor T-Cell Lymphoblastic Leukemia-Lymphoma are looking for participants at sites in Colorado.
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- Colorado Blood Cancer Institute, Denver
RecruitingPhase 2
6 Months · All sexes · Updated Sep 28, 2026 · NCT06514794Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
- Children's Hospital Colordao, Aurora
RecruitingPhase 1
Up to age 39 · All sexes · Updated Sep 11, 2026 · NCT04972942A Registry for People With T-cell Lymphoma
- University of Colorado (Data Collection Only), Aurora
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.